ESLA
Estrella Immunopharma Inc.
0.429$
-2.5%
vs. previous close
Closing price · As of: Oct 6, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -100.0% | – | – | – | – | – | +0.0% | -4.2% | -2.7% | -1.1% | -1.0% | – | |
| – | – | – | – | -68.3% | -124.0% | – | +236.0% | -22.5% | -91.8% | -1,574.3% | – | – | |
| – | – | – | +0.0% | +0.0% | +33.3% | -100.0% | – | – | – | – | – | – | |
| – | +6,422.8% | -2.2% | – | – | – | – | – | – | – | – | – | – | |
| – | +0.0% | -98.3% | +221.5% | -44.3% | -57.5% | -54.0% | – | -75.7% | -610.7% | -100.0% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -3,798.0% | – | -102.1% | -44.3% | – | -290.3% | – | -20.8% | -106.2% | – | -100.0% | – | |
| – | – | – | -112.0% | – | – | – | – | -65.4% | -178.2% | – | -427.9% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.